Persistent Asset Partners’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Persistent Asset Partners's VKTX Position: Q3 2026 in Review
Persistent Asset Partners reduced its Viking Therapeutics (VKTX) stake by 1% in Q3 2026, selling an estimated $39.4K and leaving 111,598 shares worth $3.64M. The position accounts for 1% of the portfolio, ranked #20.
Persistent Asset Partners first reported a position in VKTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $4.4M in Q2 2026. 444 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Persistent Asset Partners held 111,598 shares of Viking Therapeutics worth $3.64M as of Q3 2026.
- Persistent Asset Partners sold 1,138 Viking Therapeutics shares in Q3 2026, an estimated $39.4K.
- Viking Therapeutics made up 1% of Persistent Asset Partners's portfolio in Q3 2026, its #20 holding.
- Persistent Asset Partners first reported a position in Viking Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Persistent Asset Partners's Viking Therapeutics position peaked at $4.4M in Q2 2026.
- 444 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.